论文部分内容阅读
Recently, a number of reports about pangolin have become hot news:The Chinese Pharmacopoeia (2020 edition) has not continued to include the drug-using standards for pangolin (Manis Squama), aristolochic (Aristolochia debilis Sieb. et Zucc), celestial vine (Fibraurea recisa Pierre), and Chinese patent drug Huanglian Yanggan pills (approval number by China State Food and Drug Administration: Z200113194).